9 October 2018 - The business plan sets out our product regulation, regulatory reform, international engagement and regulatory compliance agenda for 2018-19 and the steps the TGA will take to achieve its vision.

The key priorities are identified under four main activity streams:

• Product regulation - through our core regulatory activity ('business as usual') and business process improvements.
  
• Regulatory reform - including activities associated with the continued implementation of recommendations from the Medicines and Medical Devices Regulation Review.
  
• International engagement - through activities associated with the promotion of international work sharing and regulatory convergence.
  
• Regulatory education and compliance - through monitoring, targeted compliance and enforcement activities and appropriate action.
  

Read TGA news